| [1] |
Liu P, Zhao H, Luo Y. Anti-aging implications of Astragalus membranaceus (Huangqi): a well-known Chinese tonic [J]. Aging Dis, 2017, 8(6): 868-886.
|
| [2] |
Li Y, Guo S, Zhu Y, et al. Comparative analysis of twenty-five compounds in different parts of Astragalus membranaceus var. mongholicus and Astragalus membranaceus by UPLC-MS/MS [J]. J Pharm Anal, 2019, 9(6): 392-399.
|
| [3] |
Fu J, Wang Z, Huang L, et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi) [J]. Phytother Res, 2014, 28(9): 1275-1283.
|
| [4] |
Liu Y, Xu W, Xiong Y, et al. Evaluations of the effect of HuangQi against heart failure based on comprehensive echocardiography index and metabonomics [J]. Phytomedicine, 2018, 50(2): 5-12.
|
| [5] |
Dong Z, Zhao P, Xu M, et al. Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid beta-oxidation [J]. Sci Rep, 2017, 7(1): 2691-2699.
|
| [6] |
Shanzad M, Shabbir A, Wojcikowski K, et al. The antioxidant effects of Radix Astragali (Astragalus membranaceus and related species) in protecting tissues from injury and disease [J]. Curr Drug Targets, 2016, 17(12): 1331-1340.
|
| [7] |
Agyemang K, Han L, Liu E, et al. Recent advances in Astragalus membranaceus anti-diabetic research: pharmacological effects of its phytochemical constituents [J]. Evid Based Complement Alternat Med, 2013(65): 46-48.
|
| [8] |
Wang X, Wang Y, Hu JP, et al. Astragaloside IV, a natural PPARγ agonist, reduces Aβ production in Alzheimer's disease through inhibition of BACE1 [J]. Mol Neurobiol, 2017, 54(4): 2939-2949.
|
| [9] |
Yang Q, Zhang AH, Miao JH, et al. Metabolomics biotechnology, applications, and future trends: a systematic review [J]. RSC Advances, 2019, 9(64): 37245-37257.
|
| [10] |
Wu G, Zhang W, Li H. Application of metabolomics for unveiling the therapeutic role of traditional Chinese medicine in metabolic diseases [J]. J Ethnopharmacol, 2019, 242(11): 2057.
|
| [11] |
Wang M, Chen L, Liu D, et al. Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine [J]. Chem Biol Interact, 2017, 273(1): 33-41.
|
| [12] |
Han L, Wang P, Wang Y, et al. Rapid discovery of the potential toxic compounds in polygonum multiflorum by UHPLC-Q-Orbitrap-MS-based metabolomics and correlation analysis [J]. Front Pharmacol, 2019, 10(3):2-9.
|
| [13] |
Wang R, Yu Z, Herder C, et al. Novel biomarkers for pre-diabetes identified by metabolomics [J]. Mol Syst Biol, 2012, 8(6):15-21.
|
| [14] |
Frisardi V, Panza F, Seripa D, et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology [J]. Prog Lipid Res, 2011, 50(4): 313-330.
|
| [15] |
Lin J, Liu WT, Li W, et al. Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry [J]. Clin Biochem, 2010, 43(12): 992-997.
|
| [16] |
Wu Q, Zhang H, Dong X, et al. UPLC-Q-TOF/MS based metabolomic profiling of serum and urine of hyperlipidemic rats induced by high fat diet [J]. J Pharm Anal, 2014, 4(6): 360-367.
|
| [17] |
Song X, Wang J, Wang P, et al. (1)H NMR-based metabolomics approach to evaluate the effect of Xue-Fu-Zhu-Yu decoction on hyperlipidemia rats induced by high-fat diet [J]. J Pharm Biomed Anal, 2013, 78(79):202-210.
|
| [18] |
Liu YT, Jia HM, Chang X, et al. The metabolic disturbances of isoproterenol induced myocardial infarction in rats based on a tissue targeted metabonomics [J]. Mol Biosyst, 2013, 9(11): 2823-2834.
|
| [19] |
Chen T, Ni Y, Ma X, et al. Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations [J]. Sci Rep, 2016, 6(20):59-64.
|
| [20] |
Ferrari F, Gornir A, Hoyer S, et al. Glutamate metabolism in cerebral mitochondria after ischemia and post-ischemic recovery during aging: relationships with brain energy metabolism [J]. J Neurochem, 2018, 146(4): 416-428.
|
| [21] |
Yu J, Kong L, Zhang A, et al. High-throughput metabolomics for discovering potential metabolite biomarkers and metabolic mechanism from the APPswe/PS1dE9 transgenic model of Alzheimer's disease [J]. J Proteome Res, 2017, 16(9): 3219-3228.
|
| [22] |
Fiandaca MS, Gross TJ, Johnosn TM, et al. Potential metabolomic linkage in blood between Parkinson's disease and traumatic brain injury [J]. Metabolites, 2018, 8(3):50-52.
|
| [23] |
Sasaki K. Nutrition and dopamine: an intake of tyrosine in royal jelly can affect the brain levels of dopamine in male honeybees (Apis mellifera L.) [J]. J Insect Physiol, 2016, 87(3): 45-52.
|
| [24] |
Yi L, Shi S, Wang Y, et al. Serum metabolic profiling reveals altered metabolic pathways in patients with post-traumatic cognitive impairments [J]. Sci Rep, 2016, 6(2): 13-20.
|
| [25] |
Li Y, Ju L, Hou Z, et al. Screening, verification, and optimization of biomarkers for early prediction of cardiotoxicity based on metabolomics [J]. J Proteome Res, 2015, 14(6): 2437-2445.
|
百度学术
下载:
